Detailed Information on Publication Record
2024
Critical view on antimicrobial, antibiofilm and cytotoxic activities of quinazolin-4(3H)-one derived schiff bases and their Cu(II) complexes
PINDJAKOVA, Dominika, Sarka MASCARETTI, Jana HRICOVINIOVA, Jan HOSEK, Jana GREGOROVÁ et. al.Basic information
Original name
Critical view on antimicrobial, antibiofilm and cytotoxic activities of quinazolin-4(3H)-one derived schiff bases and their Cu(II) complexes
Authors
PINDJAKOVA, Dominika, Sarka MASCARETTI (203 Czech Republic), Jana HRICOVINIOVA, Jan HOSEK (203 Czech Republic), Jana GREGOROVÁ (203 Czech Republic, belonging to the institution), Jiří KOS (203 Czech Republic, belonging to the institution), Alois CIZEK (203 Czech Republic), Zuzana HRICOVINIOVA and Josef JAMPILEK (203 Czech Republic)
Edition
Heliyon, OXFORD, ELSEVIER, 2024, 2405-8440
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.000 in 2022
Organization unit
Faculty of Medicine
UT WoS
001227020400001
Keywords in English
Quinazolinones; Schiff bases; Cu(II) complexes; Antibacterial activity; Antibiofilm effect; Cytotoxicity
Tags
International impact, Reviewed
Změněno: 2/7/2024 09:36, Mgr. Tereza Miškechová
Abstract
V originále
A series of nine 2,3-disubstituted-quinazolin-4(3 H )-one derived Schiff bases and their three Cu(II) complexes was prepared and tested for their antimicrobial activities against reference strains Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 and resistant clinical isolates of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis (VRE). All the substances were tested in vitro against Mycobacterium tuberculosis H 37 Ra ATCC 25177, M. kansasii DSM 44162 and M. smegmatis ATCC 700084. While anti-enterococcal and antimycobacterial activities were insignificant, 3-[( E )-(2-hydroxy-5-nitrobenzylidene)amino]-2-(2- hydroxy-5-nitrophenyl)-2,3-dihydroquinazolin-4(1 H )-one ( SB3 ) and its Cu(II) complex ( SB3 -Cu ) demonstrated bacteriostatic antistaphylococcal activity. In addition, both compounds, as well as the other two prepared complexes, showed antibiofilm activity, which resulted in a reduction of biofilm formation and eradication of mature S. aureus biofilm by 80% even at concentrations lower than the values of their minimum inhibitory concentrations. In addition, the compounds were tested for their cytotoxic effect on the human monocytic leukemia cell line THP-1. The antileukemic efficiency was improved by the preparation of Cu(II) complexes from the corresponding non-chelated Schiff base ligands.
Links
ROZV/28/LF10/2020, interní kód MU |
|